News & Analysis on Clinical Trial Services & Contract Research And Development
Pharmaceutical companies must start exploring ways of extending patents on their products early in their lifecycle, such as developing improved formulations of the active ingredient, even before they are launched onto the market.
A new type of drug to treat the cardiovascular disease stable angina, a chronic condition marked by recurrent episodes of suffocating chest pain from lack of oxygen to the heart muscle, has shown encouraging safety and efficacy in a Phase II trial.
German processing technology group GEA has announced new acquisitions that will increase its offering to the food and pharma industries, part of a new strategy to expand the business under parent company mg technologies.
Sigma-Aldrich's fine chemicals unit is to distribute a plant-produced recombinant aprotinin manufactured by US-based Large Scale Biology Corporation, under a new agreement announced this week.
US company Waters Corporation will this week unveil its next-generation liquid chromatograph, said to significantly improve productivity in the lab by giving scientists chromatographic run times up to nine times shorter than the fastest current HPLC...
As the annual Pittcon laboratory analysis showcase gets underway this week, a string of products with applications in drug discovery have been introduced, including new tools for proteomics and the first commercial analysis system based on...
A fall in demand from the pharmaceuticals industry has caused a significant hole in 2003 profits for German chemicals group Degussa, which implemented heavy restructuring to reduce production capacity in its fine chemicals unit.
Pharmaceutical packaging demand in the US is forecast to rise 4.7 per cent per year to $6.8 billion in 2008, driven by new Food and Drug Administration (FDA) regulations that will require unit dose containers for a range of drugs, according to market...